Prophylactic effects of caprine serum factor (CSF-I) in mice infected with Salmonella typhimurium

Drug Development Research

Volumn 54, Issue 2, 2001, Pages 45-51

  Willeford, Kenneth O ^a   Parker, Todd A ^a   Pharr, G Todd ^b   Buddington, Karyl ^c  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Immune stimulation; Immunomodulator; Murine model; Serum peptides

Indexed keywords

CAPRINE SERUM FACTOR IMMUNOMODULATOR; IMMUNOMODULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL GROWTH; COLONY FORMING UNIT; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; IMMUNOSTIMULATION; LEUKOCYTE DIFFERENTIAL COUNT; MORTALITY; MOUSE; NONHUMAN; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLEEN; SURVIVAL; TREATMENT PLANNING;

EID: 0035670234     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.1204     Document Type: Article

References (2)

1. Ansley DR. 1993. Composition and method for immunostimulation in mammals. U.S. patent No. 5,219,578, June 15.
2. Bakimer R, Guilburd B, Zurgil N, Shoenfeld Y. 1993. The effect of intravenous gammaglobulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 69: 97-102.